The Association of Clinical Research Professionals (ACRP) announces today that JDRF, the leading global organization funding type 1 diabetes (T1D) research, is the latest subscriber to ACRP’s Site License program for clinical research training.
The program provides JDRF-funded study site staff access to ACRP’s full catalog of online clinical research training programs.
With 20-plus programs included in ACRP’s eLearning curriculum delivered on a state-of-the-art Learning Management System, JDRF research study site staff now has direct access via a site license to one of the most well-respected and highest quality suite of training programs available on the market.
The proprietary, JDRF-branded hosting environment not only provides cutting-edge clinical research training, but administrator control of user and learner records.
“We are thrilled to work with JDRF as the latest organization to license the full suite of ACRP eLearning training programs,” says Jim Kremidas, ACRP Executive Director. “JDRF is an outstanding organization with a true commitment to quality and we’re honored that they trust ACRP to provide an additional element of training for researchers at JDRF-funded study sites.”
“We’re pleased to be working with ACRP to create an eLearning program on clinical trial management for select clinical trial sites funded by JDRF research grants,” said Malavi Madireddi, Ph.D., JDRF Head, Clinical Trials Management.
“JDRF is offering this free training to ensure site staff members have the tools they need to conduct safe and high-quality research, and to accelerate the development of life-changing breakthroughs to cure, prevent and treat T1D and its complications.”
ACRP’s eLearning programs are developed with the distinct goal to drive performance improvement for those engaged in clinical research. Each program delivers interactive material aimed at enhancing human subject protection, data quality, and regulatory compliance for organizations of all size within the clinical research space.
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF